Modified H2 relaxin for tumor suppression

Details for Australian Patent Application No. 2007236516 (hide)

International Classifications

Event Publications

25 March 2010 Section 223 Application Received

University Of Guelph An application to extend the time from 11 Nov 2008 to 11 Dec 2009 in which to enter the National Phase has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

13 May 2010 Section 223 Application Allowed

University Of Guelph the time in which to enter the National Phase has been extended to 11 Dec 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

20 May 2010 PCT application entered the National Phase

PCT publication WO2007/115414 Priority application(s): WO2007/115414

27 May 2010 Assignment before Grant

University of Guelph The application has been assigned to Silvertown, Joshua; Medin, Jeffrey

31 March 2011 Assignment before Grant

Silvertown, Joshua; Medin, Jeffrey The application has been assigned to Armour Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.